Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to gain practical
experience with once daily Levemir® administration in type 2 diabetes patients who were
previously treated with NPH insulins (e.g. Protaphane®) as basal insulin as part of their IIT
under normal clinical practice conditions in Lithuania